What caused the MVMD.CN stock drop today?

The slide was driven by thin liquidity and profit-taking in a volatile microcap. No major filing or clinical update was released during market hours; volume of **18,000** shares was well below the **183,578** average.

What is Meyka AI’s forecast for MVMD.CN stock?

Meyka AI's forecast model projects a quarterly scenario of **CAD 0.03** (implied **+100.00%**) and a monthly scenario of **CAD 0.01** (implied **-33.33%**). Forecasts are projections, not guarantees.

How does valuation look for Mountain Valley MD (MVMD.CN)?

Valuation is stretched: **price-to-sales 112.45** and **price-to-book 4.03** with negative earnings (EPS **-0.02**). The company shows strong current ratio but limited revenue scale.

What is Meyka AI’s grade for MVMD.CN?

Meyka AI rates MVMD.CN with a score out of 100: **59.13 (C+) — HOLD**. The grade factors in benchmark and sector comparisons, financial growth, key metrics, forecasts, and analyst signals.

CA Stocks

MVMD.CN down 25% on 22 Jan 2026: Mountain Valley MD (CNQ) needs catalyst

ByHuzaifa Zahoor January 22, 2026January 22, 2026

MVMD.CN stock dropped 25.00% in market hours on 22 Jan 2026, closing at CAD 0.015 after a low-volume session. The intraday move followed thin liquidity with 18,000 shares traded versus an average of 183,578. Investors are reacting to stretched valuation metrics and limited near-term catalysts for Mountain Valley MD Holdings Inc. (MVMD.CN) on the CNQ exchange in Canada.